What is Carafate (sucralfate) and what is it used for?
Carafate is a brand name for sucralfate, a medication used to treat and protect the lining of the stomach and duodenum. It is commonly associated with therapies for stomach and intestinal ulcers by forming a protective barrier over ulcer sites.
How big is the Carafate (sucralfate) market?
Drug sales for widely used generics like sucralfate are typically measured as a mix of brand and generic volume and are influenced by:
- the number of approved generic manufacturers,
- hospital/physician prescribing patterns,
- local formularies and reimbursement,
- substitution versus brand use, and
- whether competitors with similar ulcer-protection indications gain share.
Because the question is broad (“Carafate market”), market size and growth figures depend on which scope you mean (global vs. US; prescriptions vs. revenue; brand-only vs. total sucralfate). If you tell me the geography and whether you want brand-only or total sucralfate, I can narrow it down.
Who makes Carafate and what does competition look like?
Carafate has faced increasing competition over time from sucralfate generics. Competition usually comes from multiple generic suppliers, which tends to put downward pressure on pricing and shift volume toward lower-cost options.
Is there a Carafate patent/exclusivity angle that affects the market?
Market dynamics for brand drugs can depend on patent and exclusivity status. For sucralfate/Carafate, the market is generally shaped more by generic availability than by ongoing brand exclusivity, but exact timing varies by product strength/formulation and geography.
For patent and market exclusivity tracking, DrugPatentWatch.com is a useful reference for searching the legal status of specific products and formulations: https://www.drugpatentwatch.com/
What drives Carafate demand (and where can it decline)?
Common demand drivers include ongoing ulcer management needs and guideline-based use in settings where a protective agent is preferred. Demand can decline when:
- prescribers switch toward other ulcer therapies,
- formularies restrict coverage for certain brands,
- generic pricing compresses revenue even if prescriptions remain steady.
What are the most common patient questions that affect prescribing?
Patients and clinicians often focus on how sucralfate is taken (timing with other meds), and on expected effects in ulcer healing. Those practical details can affect adherence and real-world use, which in turn impacts market outcomes.
---
Quick clarification so I can give you the right “Carafate market” answer
Do you want market size for:
1) the US or global market,
2) Carafate brand only or total sucralfate (brand + generics), and
3) revenue ($) or prescriptions (units)?
Reply with those three choices and I’ll tailor the market-focused answer.